Pontus Pandurevic

Pontus Pandurevic

Auto-generated profile, based on publicly available information

Pontus Pandurevic

CIBM Center for Biomedical Imaging

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
MWMark Widmaier
Mark Widmaier
AKAntonia Kaiser
Antonia Kaiser
PPPontus Pandurevic
Pontus Pandurevic
SLSong-I Lim
Song-I Lim
ADAndré Döring
André Döring
LXLijing Xin
Lijing Xin
The creatine kinase (CK) is a key enzyme involved in brain bioenergetics, playing an important role in brain function and the pathogenesis of neurological and psychiatric diseases and cancers. However, imaging its activity noninvasively in the human brain remains a significant challenge. This study aims to advance 31 P magnetic resonance fingerprinting for Creatine Kinase Imaging (CKI). The method was implemented and validated on a clinical 7 Tesla MRI scanner. CKI enables whole-brain mapping of CK forward rate constant, revealing regional differences. Furthermore, a functional CKI (fCKI) study demonstrated a CK activation map in response to visual stimulation, revealing an increase in CK forward rate constant in the visual cortex. The novel imaging modalities, CKI and fCKI, have the potential to offer insights into brain bioenergetics both at rest and during activity, in both healthy and pathological conditions.

15 November 2024 in Research Square
Verified
Preprint
Open access
PDF file
MWMark Stephan Widmaier
Mark Stephan Widmaier
AKAntonia Kaiser
Antonia Kaiser
SLSong-I Lim
Song-I Lim
PPPontus Pandurevic
Pontus Pandurevic
ADAndre Döring
Andre Döring
LXLijing Xin
Lijing Xin
The creatine kinase (CK) is a key enzyme involved in brain bioenergetics, but imaging its activity noninvasively in the human brain remains a significant challenge. This study aims to advance the magnetization transfer (MT)-31P magnetic resonance fingerprinting (MRF) framework for 3D Creatine Kinase Imaging (CKI), delivering the first whole-brain CK reaction rate maps. The method was implemented and validated on a clinical 7 Tesla MRI scanner with a 49:30-minute acquisition time and the within-session reproducibility was assessed. The CKI method successfully enables the whole-brain mapping of CK reaction rates, showing robust reproducibility with coefficients of variation (CV) below 11% for 25-minute scan sessions. Furthurmore, CKI acquisition provided simultaneous mapping of adenosine triphosphate (ATP) and phosphocreatine (PCr) concentrationratios, PCr longitudinal relaxation time (T1PCr), and phosphorus-based B0 maps at a 7.2 × 7.2 × 20 mm3 resolution. CKI provides, for the first time,3D whole-brain mapping of kCK rates in high resolution, using a user-friendly, push-button approach. A functional CKI (fCKI) study demonstrated the first CK activation cluster map in response to visual stimulation, revealing a mean 17% increase in CK rates in the visual cortex. The novel imaging modalities, CKI and fCKI, have the potential to offer new insights into brain bioenergetics both at rest and during activity.